Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY

Co-Diagnostics (OTC: CODX) reported a Q4 loss of $(16.65) per share, a 53.88% increase in losses compared to $(10.82) per share in the same quarter last year. The company's sales reached $263.922 thousand, marking a 76.74% increase from $149.325 thousand in the previous year.